APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lower Extremity Exoskeleton Enhancement Device

Compare research editions
View pricing & licenses

Selected research

Industry Research

Lower Extremity Exoskeleton Enhancement Device Industry Research Report 2026

Report ID 173911900526 December 2025136 pages

Choose your research edition.

Industry ResearchLower Extremity Exoskeleton Enhancement Device Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Lower Extremity Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Lower Extremity Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lower Extremity Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Lower Extremity Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Lower Extremity Exoskeleton Enhancement Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Lower Extremity Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Lower Extremity Exoskeleton Enhancement Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Lower Extremity Exoskeleton Enhancement Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Lower Extremity Exoskeleton Enhancement Device include Alter G, B-TEMIA Inc., Cyberdyne, Ekso Bionics, Hocoma, Interactive Motion Technologies, LockHeed Martin, Myomo and Panasonic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Lower Extremity Exoskeleton Enhancement Device market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Lower Extremity Exoskeleton Enhancement Device Market by Company

Alter G

B-TEMIA Inc.

Cyberdyne

Ekso Bionics

Hocoma

Interactive Motion Technologies

LockHeed Martin

Myomo

Panasonic

Parker Hannifin

ReWalk Robotics

US Bionics

Pharos Medical Technology

Mile Bot

Shenzhen Ruihan Medical Technology

Siyi Intelligence

Lower Extremity Exoskeleton Enhancement Device Segment by Type

Smart Type

Conventional Type

Lower Extremity Exoskeleton Enhancement Device Segment by Application

Recovery Treatment

Industrial

Others

Lower Extremity Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Extremity Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Extremity Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Extremity Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Lower Extremity Exoskeleton Enhancement Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Lower Extremity Exoskeleton Enhancement Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Lower Extremity Exoskeleton Enhancement Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Lower Extremity Exoskeleton Enhancement Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Lower Extremity Exoskeleton Enhancement Device Sales (Units) of Manufacturers (2021-2026) Table 7. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Manufacturers (2021-2026) Table 8. Global Lower Extremity Exoskeleton Enhancement Device Revenue of Manufacturers (2021-2026) Table 9. Global Lower Extremity Exoskeleton Enhancement Device Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Lower Extremity Exoskeleton Enhancement Device Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Lower Extremity Exoskeleton Enhancement Device Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Product Type & Application Table 14. Global Lower Extremity Exoskeleton Enhancement Device Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Lower Extremity Exoskeleton Enhancement Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Alter G Company Information Table 19. Alter G Business Overview Table 20. Alter G Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 22. Alter G Recent Developments Table 23. B-TEMIA Inc. Company Information Table 24. B-TEMIA Inc. Business Overview Table 25. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 27. B-TEMIA Inc. Recent Developments Table 28. Cyberdyne Company Information Table 29. Cyberdyne Business Overview Table 30. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 32. Cyberdyne Recent Developments Table 33. Ekso Bionics Company Information Table 34. Ekso Bionics Business Overview Table 35. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 37. Ekso Bionics Recent Developments Table 38. Hocoma Company Information Table 39. Hocoma Business Overview Table 40. Hocoma Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 42. Hocoma Recent Developments Table 43. Interactive Motion Technologies Company Information Table 44. Interactive Motion Technologies Business Overview Table 45. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 47. Interactive Motion Technologies Recent Developments Table 48. LockHeed Martin Company Information Table 49. LockHeed Martin Business Overview Table 50. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 52. LockHeed Martin Recent Developments Table 53. Myomo Company Information Table 54. Myomo Business Overview Table 55. Myomo Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 57. Myomo Recent Developments Table 58. Panasonic Company Information Table 59. Panasonic Business Overview Table 60. Panasonic Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 62. Panasonic Recent Developments Table 63. Parker Hannifin Company Information Table 64. Parker Hannifin Business Overview Table 65. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 67. Parker Hannifin Recent Developments Table 68. ReWalk Robotics Company Information Table 69. ReWalk Robotics Business Overview Table 70. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 72. ReWalk Robotics Recent Developments Table 73. US Bionics Company Information Table 74. US Bionics Business Overview Table 75. US Bionics Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 77. US Bionics Recent Developments Table 78. Pharos Medical Technology Company Information Table 79. Pharos Medical Technology Business Overview Table 80. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 82. Pharos Medical Technology Recent Developments Table 83. Mile Bot Company Information Table 84. Mile Bot Business Overview Table 85. Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 87. Mile Bot Recent Developments Table 88. Shenzhen Ruihan Medical Technology Company Information Table 89. Shenzhen Ruihan Medical Technology Business Overview Table 90. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 92. Shenzhen Ruihan Medical Technology Recent Developments Table 93. Siyi Intelligence Company Information Table 94. Siyi Intelligence Business Overview Table 95. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio Table 97. Siyi Intelligence Recent Developments Table 98. Global Lower Extremity Exoskeleton Enhancement Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 100. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2021-2026) Table 101. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2027-2032) & (Units) Table 102. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Region (2027-2032) Table 103. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2021-2026) Table 105. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Region (2027-2032) Table 107. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 109. North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 110. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 114. Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 115. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 119. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 120. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 124. South America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 125. South America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 129. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 130. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2026) & (Units) Table 133. Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2027-2032) & (Units) Table 134. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2026) Table 135. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2027-2032) Table 136. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2026) Table 139. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2027-2032) Table 140. Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2026) & (US$/Unit) Table 141. Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2027-2032) & (US$/Unit) Table 142. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2026) & (Units) Table 143. Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2027-2032) & (Units) Table 144. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2026) Table 145. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2027-2032) Table 146. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2026) Table 149. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2027-2032) Table 150. Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2026) & (US$/Unit) Table 151. Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Lower Extremity Exoskeleton Enhancement Device Distributors List Table 155. Lower Extremity Exoskeleton Enhancement Device Customers List Table 156. Lower Extremity Exoskeleton Enhancement Device Industry Trends Table 157. Lower Extremity Exoskeleton Enhancement Device Industry Drivers Table 158. Lower Extremity Exoskeleton Enhancement Device Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Lower Extremity Exoskeleton Enhancement Device Product Image Figure 5. Global Lower Extremity Exoskeleton Enhancement Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Lower Extremity Exoskeleton Enhancement Device Market Size (2021-2032) & (US$ Million) Figure 7. Global Lower Extremity Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 8. Global Lower Extremity Exoskeleton Enhancement Device Average Price (US$/Unit) & (2021-2032) Figure 9. Smart Type Product Image Figure 10. Conventional Type Product Image Figure 11. Recovery Treatment Product Image Figure 12. Industrial Product Image Figure 13. Others Product Image Figure 14. Global Lower Extremity Exoskeleton Enhancement Device Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Lower Extremity Exoskeleton Enhancement Device Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Lower Extremity Exoskeleton Enhancement Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Lower Extremity Exoskeleton Enhancement Device Sales by Region in 2025 Figure 20. Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region in 2025 Figure 21. North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country in 2025 Figure 22. North America Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 23. North America Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021-2032) Figure 24. United States Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country in 2025 Figure 28. Europe Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 29. Europe Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021-2032) Figure 30. Germany Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Market Size by Country in 2025 Figure 41. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021-2032) Figure 43. China Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Lower Extremity Exoskeleton Enhancement Device Market Size by Country in 2025 Figure 52. South America Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 53. South America Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021-2032) Figure 54. Brazil Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size by Country in 2025 Figure 58. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Country (2021-2032) Figure 60. Egypt Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Lower Extremity Exoskeleton Enhancement Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032) Figure 66. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032) Figure 67. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Type (2021-2032) Figure 68. Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032) Figure 69. Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032) Figure 70. Global Lower Extremity Exoskeleton Enhancement Device Price (US$/Unit) by Application (2021-2032) Figure 71. Lower Extremity Exoskeleton Enhancement Device Value Chain Figure 72. Lower Extremity Exoskeleton Enhancement Device Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges

Scope & coverage.

Types
  • Smart Type
  • Conventional Type
Applications
  • Recovery Treatment
  • Industrial
  • Others
Companies covered
  • Alter G
  • B-TEMIA Inc.
  • Cyberdyne
  • Ekso Bionics
  • Hocoma
  • Interactive Motion Technologies
  • LockHeed Martin
  • Myomo
  • Panasonic
  • Parker Hannifin
  • ReWalk Robotics
  • US Bionics
  • Pharos Medical Technology
  • Mile Bot
  • Shenzhen Ruihan Medical Technology
  • Siyi Intelligence

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size (2021-2032)
  4. 2.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales (2021-2032)
  5. 2.2.3 Global Lower Extremity Exoskeleton Enhancement Device Market Average Price (2021-2032)
  6. 2.3 Lower Extremity Exoskeleton Enhancement Device by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Smart Type
  9. 2.3.3 Conventional Type
  10. 2.4 Lower Extremity Exoskeleton Enhancement Device by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Recovery Treatment
  13. 2.4.3 Industrial
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Lower Extremity Exoskeleton Enhancement Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales (Units) of Manufacturers (2021-2026)
  3. 3.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Lower Extremity Exoskeleton Enhancement Device Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Lower Extremity Exoskeleton Enhancement Device Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Product Type & Application
  8. 3.8 Global Manufacturers of Lower Extremity Exoskeleton Enhancement Device, Established Date
  9. 3.9 Global Lower Extremity Exoskeleton Enhancement Device Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Alter G
  2. 4.1.1 Alter G Company Information
  3. 4.1.2 Alter G Business Overview
  4. 4.1.3 Alter G Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  6. 4.1.5 Alter G Recent Developments
  7. 4.2 B-TEMIA Inc.
  8. 4.2.1 B-TEMIA Inc. Company Information
  9. 4.2.2 B-TEMIA Inc. Business Overview
  10. 4.2.3 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  12. 4.2.5 B-TEMIA Inc. Recent Developments
  13. 4.3 Cyberdyne
  14. 4.3.1 Cyberdyne Company Information
  15. 4.3.2 Cyberdyne Business Overview
  16. 4.3.3 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  18. 4.3.5 Cyberdyne Recent Developments
  19. 4.4 Ekso Bionics
  20. 4.4.1 Ekso Bionics Company Information
  21. 4.4.2 Ekso Bionics Business Overview
  22. 4.4.3 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  24. 4.4.5 Ekso Bionics Recent Developments
  25. 4.5 Hocoma
  26. 4.5.1 Hocoma Company Information
  27. 4.5.2 Hocoma Business Overview
  28. 4.5.3 Hocoma Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  30. 4.5.5 Hocoma Recent Developments
  31. 4.6 Interactive Motion Technologies
  32. 4.6.1 Interactive Motion Technologies Company Information
  33. 4.6.2 Interactive Motion Technologies Business Overview
  34. 4.6.3 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  36. 4.6.5 Interactive Motion Technologies Recent Developments
  37. 4.7 LockHeed Martin
  38. 4.7.1 LockHeed Martin Company Information
  39. 4.7.2 LockHeed Martin Business Overview
  40. 4.7.3 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  42. 4.7.5 LockHeed Martin Recent Developments
  43. 4.8 Myomo
  44. 4.8.1 Myomo Company Information
  45. 4.8.2 Myomo Business Overview
  46. 4.8.3 Myomo Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  48. 4.8.5 Myomo Recent Developments
  49. 4.9 Panasonic
  50. 4.9.1 Panasonic Company Information
  51. 4.9.2 Panasonic Business Overview
  52. 4.9.3 Panasonic Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  54. 4.9.5 Panasonic Recent Developments
  55. 4.10 Parker Hannifin
  56. 4.10.1 Parker Hannifin Company Information
  57. 4.10.2 Parker Hannifin Business Overview
  58. 4.10.3 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  60. 4.10.5 Parker Hannifin Recent Developments
  61. 4.11 ReWalk Robotics
  62. 4.11.1 ReWalk Robotics Company Information
  63. 4.11.2 ReWalk Robotics Business Overview
  64. 4.11.3 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  66. 4.11.5 ReWalk Robotics Recent Developments
  67. 4.12 US Bionics
  68. 4.12.1 US Bionics Company Information
  69. 4.12.2 US Bionics Business Overview
  70. 4.12.3 US Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  72. 4.12.5 US Bionics Recent Developments
  73. 4.13 Pharos Medical Technology
  74. 4.13.1 Pharos Medical Technology Company Information
  75. 4.13.2 Pharos Medical Technology Business Overview
  76. 4.13.3 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  78. 4.13.5 Pharos Medical Technology Recent Developments
  79. 4.14 Mile Bot
  80. 4.14.1 Mile Bot Company Information
  81. 4.14.2 Mile Bot Business Overview
  82. 4.14.3 Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  84. 4.14.5 Mile Bot Recent Developments
  85. 4.15 Shenzhen Ruihan Medical Technology
  86. 4.15.1 Shenzhen Ruihan Medical Technology Company Information
  87. 4.15.2 Shenzhen Ruihan Medical Technology Business Overview
  88. 4.15.3 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  90. 4.15.5 Shenzhen Ruihan Medical Technology Recent Developments
  91. 4.16 Siyi Intelligence
  92. 4.16.1 Siyi Intelligence Company Information
  93. 4.16.2 Siyi Intelligence Business Overview
  94. 4.16.3 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio
  96. 4.16.5 Siyi Intelligence Recent Developments
5 Global Lower Extremity Exoskeleton Enhancement Device Market Scenario by Region
  1. 5.1 Global Lower Extremity Exoskeleton Enhancement Device Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021-2032
  3. 5.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2021-2026
  4. 5.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2027-2032
  5. 5.3 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2021-2032
  6. 5.3.1 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2021-2026
  7. 5.3.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Region: 2027-2032
  8. 5.4 North America Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
  9. 5.4.1 North America Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  11. 5.4.3 North America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
  16. 5.5.1 Europe Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  18. 5.5.3 Europe Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
  41. 5.7.1 South America Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  43. 5.7.3 South America Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Lower Extremity Exoskeleton Enhancement Device Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032)
  2. 6.1.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032) & (Units)
  3. 6.1.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Type (2021-2032)
  4. 6.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Type (2021-2032)
  5. 6.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Lower Extremity Exoskeleton Enhancement Device Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032)
  2. 7.1.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032) & (Units)
  3. 7.1.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Market Share by Application (2021-2032)
  4. 7.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Application (2021-2032)
  5. 7.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Lower Extremity Exoskeleton Enhancement Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Lower Extremity Exoskeleton Enhancement Device Value Chain Analysis
  2. 8.1.1 Lower Extremity Exoskeleton Enhancement Device Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Lower Extremity Exoskeleton Enhancement Device Production Mode & Process
  5. 8.2 Lower Extremity Exoskeleton Enhancement Device Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Lower Extremity Exoskeleton Enhancement Device Distributors
  8. 8.2.3 Lower Extremity Exoskeleton Enhancement Device Customers
9 Global Lower Extremity Exoskeleton Enhancement Device Analyzing Market Dynamics
  1. 9.1 Lower Extremity Exoskeleton Enhancement Device Industry Trends
  2. 9.2 Lower Extremity Exoskeleton Enhancement Device Industry Drivers
  3. 9.3 Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 9.4 Lower Extremity Exoskeleton Enhancement Device Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst